Quality Indicators for the Care of Ischemic Heart Disease in Vulnerable Elders

Published in: Journal of the American Geriatrics Society, v. 55, no. S2, Oct. 2007, p. S366-S372

Posted on RAND.org on January 01, 2007

by Karol E. Watson, Constance Fung, Matthew J. Budoff

Read More

Access further information on this document at www.blackwell-synergy.com

This article was published outside of RAND. The full text of the article can be found at the link above.

Advanced age remains a strong, independent predictor of mortality from ischemic heart disease (IHD), even when controlling for other risk factors. Despite the availability of many therapies that are of proven benefit in reducing mortality and improving clinical outcomes in older patients with IHD, these treatments remain substantially underused. Advanced age also increases the risk of complications from therapies aimed at preventing cardiac death. Thus, a delicate balance must be struck when deciding which therapies will provide overall benefit. This article investigates quality indicators (QIs) that could be applied when treating vulnerable elders (VE) for IHD and review the available data in support of each of these indicators. METHODS: A total of 367 articles were considered in this review: 46 identified through a Web search, 118 through reference mining, and 203 through the Assessing Care of Vulnerable Elders (ACOVE)-3 literature searches. RESULTS: Of the 21 potential QIs, the expert panel process judged 17 to be valid, three were rejected, and two were combined. One QI was added from Quality Indicators for Screening and Prevention in Vulnerable Elders. The literature that supports each of the indicators judged to be valid in the expert panel process is described.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/research-integrity.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.